mission quality & patents

Eternally committed to innovation and quality

 

 

Mission Statement

EmCyte Corporation is committed to the continual development and improvement of devices used for autologous regenerative biologics and to the promotion of autologous therapies used to enhance the quality of life.

 

Quality Policy

EmCyte Corporation mission is to commit to the continual development and improvement of devices used for autologous regenerative biologics and to the promotion of autologous therapies used to enhance the quality of life. EmCyte missions can be fulfilled by the following key objectives:

 

  1. Providing quality products with competitive pricing
  2. Maintaining partnership with suppliers that provide quality products
  3. Providing friendly work environment for our employees
  4. Committing to meet customer requirements and to achieve highest level of customer satisfaction
  5. Providing post-production programs to ensure EmCyte products are continually monitored for compliance and performance.
  6. Aiming to grow domestically and internationally

 

EmCyte maintain an Integrated Quality Management System (IQMS) to meet the medical device regulations requirements of the FDA Quality System Regulations (21 CFR Part 820), EU Medical Device Directive (MDD 93/42/EEC) and the medical device quality standard requirements of EN ISO 13485:2016. We will comply with all applicable regulatory requirements and continually improve the effectiveness of our IQMS. The management team will periodically review the performance of the IQMS and our quality objectives. This quality policy is regularly communicated to our employees and reviewed by the Management Team for its continuing suitability. Our employees will recognize EmCyte Corporation as the best organization to work for. We will maintain a profitable operation to establish our competitive position in the market.

 

Quality Manufacturing

EmCyte Corporation is a medical manufacturing company. Our devices are cleared for marketing through both CDRH and CBER divisions of the FDA.  We have over 21 years of medical device manufacturing experience and continue to develop products that are on the cutting edge of medical excellence.  We use state-of-the-art manufacturing equipment in a modernized facility with certified clean rooms to deliver products with the highest safety and quality standard.  Our assembly and packaging operations are efficient and reliable, providing us with the ability to develop a variety of custom projects for dedicated customers.

 

FDA 510(K)

BK050055, K070666, K024080, K183205, K191564, BK190317

 

Trademarks & Patents

EmCyte is owner of a number of worldwide trademarks and patents. EmCyte protects its intellectual property. The following products are protected by patents in the U.S.A. and elsewhere. This information is provided on this web page to satisfy the virtual patent marking provisions of the America Invents Act. The patents and trademark listed cover the full scope of EmCyte products however they are not wholly restricted to their designs for functionality.  Product design or processes not listed may be protected by US or foreign patents. 

 

Patents:

 

Trademarks:

EmCyte Corporation®
Registration Number 4600238, 4600228

EmStyle®
Registration Number 5096727

PurePRP®
Registration Number 4243377, 4227568

PureBMC®
Registration Number 4623664

Progenikine®
Registration Number 5042159, 5042158

Autolothrom®
Registration Number 5834135